Merrem (Meropenem Anhydrous)

• Merrem is a carbapenem antibiotic used to treat severe bacterial infections in various organ systems.
• Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure in patients with peritonitis or intra‑abdominal abscesses.
• Complicated urinary tract infections: provides rapid bactericidal activity against resistant uropathogens, facilitating resolution of pyelonephritis and cystitis.
• Nosocomial pneumonia: penetrates lung tissue to eliminate multidrug‑resistant organisms, improving respiratory function and survival.
• Septicemia: delivers high plasma concentrations that rapidly clear bloodstream infections caused by Gram‑negative bacilli.
• Meningitis: attains therapeutic levels in cerebrospinal fluid to treat bacterial meningitis effectively.

• Meropenem exerts its antibacterial effect by binding to penicillin‑binding proteins (PBPs) on the bacterial cell wall. This inhibition prevents the cross‑linking of peptidoglycan strands, weakening the cell wall and leading to osmotic lysis. Its high affinity for a broad range of PBPs confers activity against many Gram‑negative and Gram‑positive organisms, including those resistant to other β‑lactams. Additionally, meropenem is stable against most β‑lactamases, preserving its potency.

Meropenem may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild to moderate feeling of stomach upset.
• Diarrhea: loose stools that may be watery.
• Elevated liver enzymes: transient increase in ALT/AST.
• Injection site reactions: erythema or discomfort at the infusion site.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment or high doses.
• Clostridioides difficile colitis: severe diarrhea due to intestinal flora disruption.
• Anaphylaxis: acute hypersensitivity reaction requiring immediate medical attention.

When using Merrem, clinicians should observe several precautionary measures to minimize risks.

• Renal function: assess and adjust dose in patients with impaired kidney function.
• Neurotoxicity: monitor for seizures or altered mental status, particularly in the elderly.
• Allergy history: avoid use in patients with known hypersensitivity to carbapenems or β‑lactams.
• Concomitant nephrotoxic drugs: use caution when combined with aminoglycosides or vancomycin.
• Pregnancy and lactation: weigh potential benefits against unknown risks; use only if clearly indicated.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Merrem can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: co‑administration may reduce valproate levels, risking seizure breakthrough.
• High‑dose aminoglycosides: increased risk of nephrotoxicity and ototoxicity.
• Loop diuretics: may exacerbate renal impairment, requiring dose adjustment.

Moderate Interactions (Monitor Closely)

• Probenecid: may decrease renal clearance of meropenem, leading to higher plasma concentrations.
• Warfarin: monitor INR as meropenem can potentiate anticoagulant effect.
• Other β‑lactam antibiotics: avoid concurrent use to prevent antagonistic effects.